Abstract
Background Satisfying patients’ preferences is an important outcome in palliative care. Previous research has reported that a patient’s place of death was associated with quality of death and dying.
Purpose This study aimed to assess factors associated with congruence between a patient’s preferred and actual place of death and their quality of death and dying, as perceived by their family caregivers.
Method Data were obtained from a nationwide cross-sectional questionnaire survey of bereaved family caregivers of patients with cancer in Japan. A total of 13,711 family caregivers participated. We evaluated the quality of death and dying using the Good Death Inventory.
Results Patients who died in their preferred place were categorized as the “achieved group,” whereas patients who died in a place that they did not prefer were classified as the “not-achieved group.” Survey scores were significantly higher for the achieved group compared with the not-achieved group (48.8±10.1 and 44.0±9.5, respectively; p <0.001). A multiple linear regression analysis indicated that congruence between preferred and actual place of death was an independent determinant of good quality of death and dying (p <0.001).
Conclusion Congruence between a patient’s preferred and actual place of death may contribute to better quality of death and dying among terminally ill patients with cancer. Congruence between preferred and actual place of death should be regarded as an essential goal in end-of-life care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the institutional review board of Tohoku University (2013-1-334) and all participating institutions.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
